Search research articles
Contact Us
Filters
Showing results (111-120 of 246) with videos related to
Page
of 25
Sort By:
Pancreas
|
September 22, 2015
A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma
Andrew H Ko, Noelle LoConte, Margaret A Tempero, et al.
Therapeutic Advances in Medical Oncology
|
November 20, 2024
Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma-a real-world, multicenter study
Michael Li, Lindsay M Hannan, Lipika Goyal, et al.
NAR Genomics and Bioinformatics
|
June 30, 2025
Novel treatment-specific causal biomarkers for colorectal cancer by omics integration
Akram Yazdani, Azam Yazdani, Raul Mendez-Giraldez, et al.
International Journal of Colorectal Disease
|
August 14, 2024
Association between gastrointestinal symptoms and specialty care utilization among colon cancer survivors: a cohort study
Anya L Edwards, Karen Trang, Irina V Tolstykh, et al.
Journal of the National Cancer Institute
|
August 30, 2024
Plant-based diet and survival among patients with metastatic colorectal cancer
En Cheng, Fang-Shu Ou, Clare Gatten, et al.
Liver Cancer
|
December 24, 2021
Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling
Robin K Kelley, Nancy M Joseph, Halla S Nimeiri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2005
Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer
Kshama R Mehta, Kentaro Nakao, Marlene B Zuraek, et al.
Cancer
|
August 10, 2021
Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931)
Rebecca A Snyder, Jun He, Jennifer Le-Rademacher, et al.
NPJ Precision Oncology
|
March 24, 2023
Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data
Travis Zack, Kurt P Losert, Samantha M Maisel, et al.
The Oncologist
|
May 14, 2020
A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma
Imane El Dika, Robert J Mayer, Alan P Venook, et al.
Page
of 25
Search research articles
Search
Showing results (111-120 of 246) with videos related to
Sort By:
Page
of 25
Pancreas
|
September 22, 2015
A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma
Andrew H Ko, Noelle LoConte, Margaret A Tempero, et al.
Therapeutic Advances in Medical Oncology
|
November 20, 2024
Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma-a real-world, multicenter study
Michael Li, Lindsay M Hannan, Lipika Goyal, et al.
NAR Genomics and Bioinformatics
|
June 30, 2025
Novel treatment-specific causal biomarkers for colorectal cancer by omics integration
Akram Yazdani, Azam Yazdani, Raul Mendez-Giraldez, et al.
International Journal of Colorectal Disease
|
August 14, 2024
Association between gastrointestinal symptoms and specialty care utilization among colon cancer survivors: a cohort study
Anya L Edwards, Karen Trang, Irina V Tolstykh, et al.
Journal of the National Cancer Institute
|
August 30, 2024
Plant-based diet and survival among patients with metastatic colorectal cancer
En Cheng, Fang-Shu Ou, Clare Gatten, et al.
Liver Cancer
|
December 24, 2021
Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling
Robin K Kelley, Nancy M Joseph, Halla S Nimeiri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2005
Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer
Kshama R Mehta, Kentaro Nakao, Marlene B Zuraek, et al.
Cancer
|
August 10, 2021
Racial differences in survival and response to therapy in patients with metastatic colorectal cancer: A secondary analysis of CALGB/SWOG 80405 (Alliance A151931)
Rebecca A Snyder, Jun He, Jennifer Le-Rademacher, et al.
NPJ Precision Oncology
|
March 24, 2023
Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data
Travis Zack, Kurt P Losert, Samantha M Maisel, et al.
The Oncologist
|
May 14, 2020
A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma
Imane El Dika, Robert J Mayer, Alan P Venook, et al.
Page
of 25